Projections of Global Mortality and Burden of Disease from 2002 to 2030

Mathers, Colin D.; Loncar, Dejan
November 2006
PLoS Medicine;Nov2006, Vol. 3 Issue 11, p2011
Academic Journal
Background Global and regional projections of mortality and burden of disease by cause for the years 2000, 2010, and 2030 were published by Murray and Lopez in 1996 as part of the Global Burden of Disease project. These projections, which are based on 1990 data, continue to be widely quoted, although they are substantially outdated; in particular, they substantially underestimated the spread of HIV/AIDS. To address the widespread demand for information on likely future trends in global health, and thereby to support international health policy and priority setting, we have prepared new projections of mortality and burden of disease to 2030 starting from World Health Organization estimates of mortality and burden of disease for 2002. This paper describes the methods, assumptions, input data, and results. Methods and Findings Relatively simple models were used to project future health trends under three scenarios—baseline, optimistic, and pessimistic—based largely on projections of economic and social development, and using the historically observed relationships of these with cause-specific mortality rates. Data inputs have been updated to take account of the greater availability of death registration data and the latest available projections for HIV/AIDS, income, human capital, tobacco smoking, body mass index, and other inputs. In all three scenarios there is a dramatic shift in the distribution of deaths from younger to older ages and from communicable, maternal, perinatal, and nutritional causes to noncommunicable disease causes. The risk of death for children younger than 5 y is projected to fall by nearly 50% in the baseline scenario between 2002 and 2030. The proportion of deaths due to noncommunicable disease is projected to rise from 59% in 2002 to 69% in 2030. Global HIV/AIDS deaths are projected to rise from 2.8 million in 2002 to 6.5 million in 2030 under the baseline scenario, which assumes coverage with antiretroviral drugs reaches 80% by 2012. Under the optimistic scenario, which also assumes increased prevention activity, HIV/AIDS deaths are projected to drop to 3.7 million in 2030. Total tobacco-attributable deaths are projected to rise from 5.4 million in 2005 to 6.4 million in 2015 and 8.3 million in 2030 under our baseline scenario. Tobacco is projected to kill 50% more people in 2015 than HIV/AIDS, and to be responsible for 10% of all deaths globally. The three leading causes of burden of disease in 2030 are projected to include HIV/AIDS, unipolar depressive disorders, and ischaemic heart disease in the baseline and pessimistic scenarios. Road traffic accidents are the fourth leading cause in the baseline scenario, and the third leading cause ahead of ischaemic heart disease in the optimistic scenario. Under the baseline scenario, HIV/AIDS becomes the leading cause of burden of disease in middle- and low-income countries by 2015. Conclusions These projections represent a set of three visions of the future for population health, based on certain explicit assumptions. Despite the wide uncertainty ranges around future projections, they enable us to appreciate better the implications for health and health policy of currently observed trends, and the likely impact of fairly certain future trends, such as the ageing of the population, the continued spread of HIV/AIDS in many regions, and the continuation of the epidemiological transition in developing countries. The results depend strongly on the assumption that future mortality trends in poor countries will have a relationship to economic and social development similar to those that have occurred in the higher-income countries.


Related Articles

  • FEASIBILITY OF CHEMOPROPHYLAXIS STUDIES IN HIGH RISK HIV-SERONEGATIVE POPULATION. Gross, Michael; Holte, Sarah; Seage, George R.; Buchbinder, Susan P.; Metzger, David S.; Mayer, Kenneth H. // AIDS Education & Prevention;Feb2000, Vol. 12 Issue 1, p71 

    This article reports that administration of antiretroviral medications-recommended to prevent HIV infection after occupational exposure-has not been evaluated for safety or efficacy following non occupational exposure. Although plausible, the safety and biological efficacy of oral...

  • Antenatal HIV Screening and Treatment in South Africa: Social Norms and Policy Options. Hasnain, Memoona // African Journal of Reproductive Health;Aug2004, Vol. 8 Issue 2, p77 

    South Africa has one of the highest prevalence of HIV and AIDS in the world, with mother-to-child transmission being an important route for spread of the infection. For years, AIDS scientists and activists locally and internationally have been working desperately for the people of South Africa...

  • Integrating HIV Prevention and Treatment: From Slogans to Impact. Salomon, Joshua A.; Hogan, Daniel R.; Stover, John; Stanecki, Karen A.; Walker, Neff; Ghys, Peter D.; Schwartländer, Bernhard // PLoS Medicine;Jan2005, Vol. 2 Issue 1, p50 

    Background Through major efforts to reduce costs and expand access to antiretroviral therapy worldwide, widespread delivery of effective treatment to people living with HIV/AIDS is now conceivable even in severely resource-constrained settings. However, the potential epidemiologic impact of...

  • Comparing State-Only Expenditures for AIDS. Rowe, Mona J.; Ryan, Caitlin C. // American Journal of Public Health;Apr88, Vol. 78 Issue 4, p424 

    The State AIDS Policy Center at the Inter-governmental Health Policy Project (IHPP) at George Washington University surveyed all 50 states to determine state AIDS (acquired immunodeficiency syndrome) expenditures, without Medicaid or federal funds, for fiscal 1984–88. During this period,...

  • Youth and HIV/AIDS in Africa: A Call for Effective Policies and Programs. Odaga, Adhiambo // African Journal of Reproductive Health;Jun2012, Vol. 16 Issue 2, p17 

    The author reflects on the need for effective policies and programs to address HIV and AIDS in youth in Africa. The author suggests that African youth are vulnerable to acquiring HIV and AIDS and that the prevalence of the diseases among African youth is 2.3%. The author argues that there is a...

  • La Jeunesse et le VIH/SIDA en Afrique : Demande des politiques et de programmes efficaces. Odaga, Adhiambo // African Journal of Reproductive Health;Jun2012, Vol. 16 Issue 2, p20 

    The author reflects on the need for effective policies and programs to address HIV and AIDS in youth in Africa. The author suggests that African youth are vulnerable to acquiring HIV and AIDS and that the prevalence of the diseases among African youth is 2.3%. The author argues that there is a...

  • A retrospective study of Human Immunodeficiency Virus transmission, mortality and loss to follow-up among infants in the first 18 months of life in a prevention of mother-to-child transmission programme in an urban hospital in KwaZulu-Natal, South Africa. Chetty, Terusha; Knight, Stephen; Giddy, Janet; Crankshaw, Tamaryn L.; Butler, Lisa M.; Newell, Marie-Louise // BMC Pediatrics;2012, Vol. 12 Issue 1, p146 

    Background: Follow up of Human Immunodeficiency Virus (HIV)-exposed infants is an important component of Prevention of Mother-to-Child Transmission (PMTCT) programmes in order to ascertain infant outcomes post delivery. We determined HIV transmission, mortality and loss to follow-up (LTFU) of...

  • Coping with HIV in Pakistan.  // Contemporary Sexuality;Oct2011, Vol. 45 Issue 10, p8 

    The article presents information on efforts to treat and prevent HIV and AIDS in Pakistan, noting how intravenous drug users and migrant workers returning from Arab states have increased concerns of HIV transmission.

  • Stretching To Meet Global Health Needs. Dentzer, Susan // Health Affairs;Nov/Dec2009, Vol. 28 Issue 6, p1572 

    The article discusses various reports published within the issue, including one by Anil Soni and Rajat Gupta on the lack of funding to deal with HIV and AIDS disease, one by Philip Musgrove on the need to extend fundings to alleviate the HIV/AIDS pandemic, and one by Margaret Humphreys on modern...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics